HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclc-knockout mice, providing a model for hepatic cirrhosis.

AbstractBACKGROUND & AIMS:
Certain liver diseases have been associated with depletion of glutathione (GSH), the major antioxidant in the liver. A recent report about Gclc(h/h) mice with a hepatocyte-specific ablation of Gclc (the gene encoding the catalytic subunit of the rate-limiting enzyme in GSH synthesis) has shown an essential role of GSH in hepatic function. Gclc(h/h) mice develop severe steatosis and die of liver failure within one month, due to ~95% depletion of hepatic GSH; mitochondria are the major affected organelles, displaying abnormal ultrastructure and impaired functioning.
METHODS:
Gclc(h/h) mice were fed with L-N-acetylcysteine (NAC; 10 g/L) in drinking water, starting at postnatal day 18.
RESULTS:
Gclc(h/h) mice were rescued by use of NAC supplementation, and survived until adulthood. NAC replenished the mitochondrial GSH pool and attenuated mitochondrial damage, with accompanying diminished hepatic steatosis; however, abnormal liver biochemical tests, hepatocyte death, and hepatic oxidative stress persisted in the rescued mice. At 50 days of age, the liver from rescued Gclc(h/h) mice started to display characteristics of fibrosis and at age 120 days, macronodular cirrhosis was observed. Immunohistostaining for liver-specific markers as well as the expression profile of hepatic cytokines indicated that the repopulation of hepatocytes in the cirrhotic nodules involved the expansion of oval cells.
CONCLUSIONS:
Replenishment of mitochondrial GSH and restoration of mitochondrial function by NAC prevents mortality caused by the loss of hepatocyte GSH de novo synthesis, allowing steatosis to progress to a chronic stage. Thus, with NAC supplementation, Gclc(h/h) mice provide a model for the development of liver fibrosis and cirrhosis.
AuthorsYing Chen, Elisabet Johansson, Yi Yang, Marian L Miller, Dongxiao Shen, David J Orlicky, Howard G Shertzer, Vasilis Vasiliou, Daniel W Nebert, Timothy P Dalton
JournalJournal of hepatology (J Hepatol) Vol. 53 Issue 6 Pg. 1085-94 (Dec 2010) ISSN: 1600-0641 [Electronic] Netherlands
PMID20810184 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Antioxidants
  • Cytokines
  • DNA Primers
  • RNA, Messenger
  • Glutamate-Cysteine Ligase
  • Glutathione
  • Acetylcysteine
Topics
  • Acetylcysteine (administration & dosage)
  • Administration, Oral
  • Animals
  • Antioxidants (metabolism)
  • Base Sequence
  • Cytokines (genetics)
  • DNA Primers (genetics)
  • Disease Models, Animal
  • Gene Expression Profiling
  • Glutamate-Cysteine Ligase (deficiency, genetics, metabolism)
  • Glutathione (metabolism)
  • Hepatocytes (drug effects, metabolism, ultrastructure)
  • Liver (drug effects, metabolism, pathology)
  • Liver Cirrhosis (etiology, genetics, metabolism, pathology)
  • Mice
  • Mice, Knockout
  • Microscopy, Electron, Transmission
  • Mitochondria, Liver (drug effects, metabolism)
  • Oxidative Stress (drug effects)
  • RNA, Messenger (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: